October 26

Homeland Security bill_ – Pharma Immunity – WP

Homeland Security bill – Pharma Immunity – WP

Fri, 15 Nov 2002

The Homeland Security bill that passed the House includes sweeping last minute provisions attached to it that have nothing to do with the war on terrorism. The provisions put the interest of pharmaceutical industry giants above the health and welfare of the public.

Of particular concern is a White House-backed provision that would give pharmaceutical companies immunity from liability for adulterated products–such as drugs and vaccines–even if the manufacturer is willfully negligent in using adulterated products! According to the new bill such items would could escape from liability lawsuits, simply by being designated by the head of the homeland security department as “necessary for security purposes.”

See: Controversial provisions could delay Senate homeland vote By Brody Mullins and April Fulton, CongressDaily

Eli Lilly could be the first beneficiary of the Homeland Security bill would immunize the company from legal action by parents who suspect that their children’s autism was caused by the mercury-laced vaccine preservative, thimerosal.

The sweeping provisions of the Homeland Security bill–including exemption from Freedom of Information provisions–can be interpreted as an opportunistic move by special interest groups to suspend citizens’ legal rights and protections.

As Dallas Attorney Andrew Waters told the Washington Post: “The industry has seized the opportunity presented by a Republican House and Senate to immediately pass legislation to get the industry off the hook. To me, it looks like payback for the fact that the industry spent millions bankrolling Republican campaigns.”

The Senate is scheduled to consider the bill today, Friday, Nov 16th.




Homeland Bill Rider Aids Drugmakers

Measure Would Block Suits Over Vaccines; FBI Powers Also Would Grow

By Dan Morgan

Washington Post Staff Writer

Friday, November 15, 2002; Page A07

Riding along on legislation to create a new federal Department of Homeland Security is a White House-backed provision that could head off dozens of potential lawsuits against Eli Lilly and Co. and other pharmaceutical giants.

Elsewhere in the sprawling measure is language that would help the FBI obtain customer information from Internet service providers and increase the penalties for computer hacking. These and other last-minute additions to the bill by Republican leaders could have implications well beyond the measure’s immediate goal of protecting the homeland, congressional officials said yesterday.

Lawyers for parents of autistic children suing pharmaceutical companies over childhood vaccines charged yesterday that a new section in the homeland bill — passed on Wednesday by the House and now before the Senate — would keep the lawsuits out of state courts, ruling out huge judgments and lengthy litigation. Complaints, instead, would be channeled to a federal program set up 14 years ago to provide liability protection for vaccine manufacturers. The program, funded through a surcharge on vaccines, compensates persons injured by such vaccines, to a maximum of $250,000.

“The industry has seized the opportunity presented by a Republican House and Senate to immediately pass legislation to get the industry off the hook,” said Dallas lawyer Andrew Waters. “To me, it looks like payback for the fact that the industry spent millions bankrolling Republican campaigns.”

GOP officials said the provisions are merely aimed at protecting companies working on life-saving products from being dragged into costly litigation by trial lawyers. Pharmaceutical companies were among the largest contributors to Republicans in this year’s elections, while trial lawyers heavily backed Democrats.

In the past several years, some families have alleged a connection between their children’s autism and vaccines using the preservative Thimerosal, which contains mercury. Medical studies have not proven a connection between Thimerosal and autism, but companies stopped using the preservative several years ago.

Eli Lilly, once the largest maker of Thimerosal, is a major target in a spate of lawsuits filed since 2000. The company stopped making the product in 1980 but continued to buy it from other manufacturers and to resell it for another decade.

Company spokesman Edward Sagebiel said Lilly was “surprised when the language was inserted” because it had not actively lobbied for it in recent months. But he said the company “believes it is a positive step to help assure that manufacturers are protected from lawsuits that are without merit or scientific evidence.”

Richard Diamond, a spokesman for retiring House Majority Leader Richard K. Armey (R-Tex.), said the provision was inserted because “it was something the White House wanted. It wasn’t [Armey’s] idea.” But Diamond said the principle is good. “We don’t want companies to be steered away from the business of making things that can save lives,” he said.

Elsewhere in the bill, Republicans incorporated the entire Cyber Security Enhancement Act, which the House passed overwhelmingly in July but which made little progress in the Democratic-controlled Senate. To strengthen law enforcement’s hand in protecting the security of computer communications, the legislation would increase penalties for hacking and other malicious computing. Privacy advocates have criticized some provisions, particularly those that would lower the threshold for Internet service providers to give law enforcement agencies customer communications without a court order.

The bill would make hacking punishable by as much as life in prison if the offender “knowingly or recklessly causes or attempts to cause death.”

Cut from the bill was a Democratic-backed provision that would have prevented the new federal agency from giving contracts to U.S.-based companies that use offshore addresses to avoid corporate taxes.

GOP aides said the language originally offered by Rep. Tom DeLay (R-Tex.), and now incorporated in the bill, gives Texas A&M the inside track in hosting the first university center on homeland security, to be established within one year. DeLay was elected Wednesday to serve as the House majority leader in the 108th Congress.

Yesterday, Senate Democrats were considering trying to strip non-relevant provisions from the homeland security bill during the final debate. If successful, such a move could derail Congress’s timetable for adjourning, by forcing a new round of House-Senate negotiations to resolve differences in the legislation.

Staff writer Jonathan Krim contributed to this report.

© 2002 The Washington Post Company

FAIR USE NOTICE: This may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml If you wish to use copyrighted material for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

Subscribe To Our Newsletter!

Sign up and be the first to find out the latest news and articles about what's going on in the medical field.

You may also like

November 21, 2023

Vera Sharav is joining Christine Anderson as special guest for the Make It Your Business event in

Read More
Vera Sharav Joins Christine Anderson for Make It Your Business – Dec 4, 2023 in New Jersey

November 21, 2023

Vera Sharav is premiering the movie Never Again is Now Global in New York City, December 1.

Read More
Never Again is Now Global – Premiere Screening – Dec 1, 2023 in New York City